- Home
- PODD vs EXPE Comparison
PODD vs EXPE Comparison
Compare PODD & EXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- EXPE
- Stock Information
- Founded
- PODD 2000
- EXPE 1996
- Country
- PODD United States
- EXPE United States
- Employees
- PODD N/A
- EXPE N/A
- Industry
- PODD Medical/Dental Instruments
- EXPE Transportation Services
- Sector
- PODD Health Care
- EXPE Consumer Discretionary
- Exchange
- PODD Nasdaq
- EXPE Nasdaq
- Market Cap
- PODD 22.1B
- EXPE 26.7B
- IPO Year
- PODD 2007
- EXPE 1999
- Fundamental
- Price
- PODD $333.84
- EXPE $241.56
- Analyst Decision
- PODD Strong Buy
- EXPE Buy
- Analyst Count
- PODD 18
- EXPE 29
- Target Price
- PODD $354.17
- EXPE $248.19
- AVG Volume (30 Days)
- PODD 562.0K
- EXPE 2.5M
- Earning Date
- PODD 11-06-2025
- EXPE 11-06-2025
- Dividend Yield
- PODD N/A
- EXPE 0.67%
- EPS Growth
- PODD N/A
- EXPE 35.97
- EPS
- PODD 3.45
- EXPE 10.37
- Revenue
- PODD $2,521,800,000.00
- EXPE $14,370,000,000.00
- Revenue This Year
- PODD $29.32
- EXPE $6.73
- Revenue Next Year
- PODD $18.37
- EXPE $6.36
- P/E Ratio
- PODD $96.64
- EXPE $23.14
- Revenue Growth
- PODD 27.11
- EXPE 7.29
- 52 Week Low
- PODD $230.05
- EXPE $130.01
- 52 Week High
- PODD $353.50
- EXPE $279.61
- Technical
- Relative Strength Index (RSI)
- PODD 58.72
- EXPE 52.62
- Support Level
- PODD $311.51
- EXPE $208.44
- Resistance Level
- PODD $341.03
- EXPE $279.61
- Average True Range (ATR)
- PODD 12.17
- EXPE 10.00
- MACD
- PODD 1.52
- EXPE 1.24
- Stochastic Oscillator
- PODD 86.32
- EXPE 45.82
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
About EXPE Expedia Group Inc.
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.